Local activation of cardiac stem cells for post-myocardial infarction cardiac repair

Journal of Cellular and Molecular Medicine

Volumn 16, Issue 11, 2012, Pages 2549-2563

  Wen, Zhuzhi ^a   Mai, Zun ^a   Zhang, Haifeng ^a   Chen, Yangxin ^a   Geng, Dengfeng ^a   Zhou, Shuxian ^a   Wang, Jingfeng ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Cardiac stem cells; Endogenous regeneration; Myocardial infarction

Indexed keywords

MICRORNA; SIGNAL PEPTIDE;

ADULT; ANIMAL; ARTICLE; CELL COMMUNICATION; CYTOLOGY; HEART; HEART INFARCTION; HEART MUSCLE; HUMAN; METABOLISM; METHODOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REGENERATION; STEM CELL; STEM CELL TRANSPLANTATION;

ADULT; ANIMALS; CELL COMMUNICATION; HEART; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICRORNAS; MYOCARDIAL INFARCTION; MYOCARDIUM; REGENERATION; STEM CELL TRANSPLANTATION; STEM CELLS;

ANIMALIA;

EID: 84868152542     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2012.01589.x     Document Type: Article

References (171)

1. Wen Z, Zheng S, Zhou C, et al. Repair mechanisms of bone marrow mesenchymal stem cells in myocardial infarction. J Cell Mol Med. 2011; 15: 1032-43.
2. Makino S, Fukuda K, Miyoshi S, et al. Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest. 1999; 103: 697-705.
3. Zhang Y, Wang D, Chen M, et al. Intramyocardial transplantation of undifferentiated rat induced pluripotent stem cells causes tumorigenesis in the heart. PLoS One. 2011; 6: e19012.
4. Ahmed RP, Ashraf M, Buccini S, et al. Cardiac tumorigenic potential of induced pluripotent stem cells in an immunocompetent host with myocardial infarction. Regen Med. 2011; 6: 171-8.
5. Bergmann O, Bhardwaj RD, Bernard S, et al. Evidence for cardiomyocyte renewal in humans. Science. 2009; 324: 98-102.
6. Reinecke H, Minami E, Zhu WZ, et al. Cardiogenic differentiation and transdifferentiation of progenitor cells. Circ Res. 2008; 103: 1058-71.
7. Bu L, Jiang X, Martin-Puig S, et al. Human ISL1 heart progenitors generate diverse multipotent cardiovascular cell lineages. Nature. 2009; 460: 113-7.
8. Mouquet F, Pfister O, Jain M, et al. Restoration of cardiac progenitor cells after myocardial infarction by self-proliferation and selective homing of bone marrow-derived stem cells. Circ Res. 2005; 97: 1090-2.
9. Lu G, Haider HK, Jiang S, et al. Sca-1+ stem cell survival and engraftment in the infarcted heart: dual role for preconditioning-induced connexin-43. Circulation. 2009; 119: 2587-96.
10. Beltrami AP, Barlucchi L, Torella D, et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell. 2003; 114: 763-76.
11. Hatzistergos KE, Quevedo H, Oskouei BN, et al. Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation. Circ Res. 2010; 107: 913-22.
12. Takehara N, Tsutsumi Y, Tateishi K, et al. Controlled delivery of basic fibroblast growth factor promotes human cardiosphere-derived cell engraftment to enhance cardiac repair for chronic myocardial infarction. J Am Coll Cardiol. 2008; 52: 1858-65.
13. Urbanek K, Torella D, Sheikh F, et al. Myocardial regeneration by activation of multipotent cardiac stem cells in ischemic heart failure. Proc Natl Acad Sci USA. 2005; 102: 8692-7.
14. Torella D, Ellison GM, Mendez-Ferrer S, et al. Resident human cardiac stem cells: role in cardiac cellular homeostasis and potential for myocardial regeneration. Nat Clin Pract Cardiovasc Med. 2006; 3: S8-13.
15. Barile L, Messina E, Giacomello A, et al. Endogenous cardiac stem cells. Prog Cardiovasc Dis. 2007; 50: 31-48.
16. Nadal-Ginard B, Anversa P, Kajstura J, et al. Cardiac stem cells and myocardial regeneration. Novartis Found Symp. 2005; 265: 142-54; discussion 55-7, 204-11.
17. Bearzi C, Rota M, Hosoda T, et al. Human cardiac stem cells. Proc Natl Acad Sci USA. 2007; 104: 14068-73.
18. Linke A, Muller P, Nurzynska D, et al. Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function. Proc Natl Acad Sci USA. 2005; 102: 8966-71.
19. Leri A, Kajstura J, Anversa P. Cardiac stem cells and mechanisms of myocardial regeneration. Physiol Rev. 2005; 85: 1373-416.
20. Urbanek K, Rota M, Cascapera S, et al. Cardiac stem cells possess growth factor-receptor systems that after activation regenerate the infarcted myocardium, improving ventricular function and long-term survival. Circ Res. 2005; 97: 663-73.
21. Braun T, Martire A. Cardiac stem cells: paradigm shift or broken promise? A view from developmental biology. Trends Biotechnol. 2007; 25: 441-7.
22. Torella D, Indolfi C, Goldspink DF, et al. Cardiac stem cell-based myocardial regeneration: towards a translational approach. Cardiovasc Hematol Agents Med Chem. 2008; 6: 53-9.
23. Hosoda T, Zheng H, Cabral-da-Silva M, et al. Human cardiac stem cell differentiation is regulated by a mircrine mechanism. Circulation. 2011; 123: 1287-96.
24. Serpi R, Tolonen AM, Tenhunen O, et al. Divergent effects of losartan and metoprolol on cardiac remodeling, c-kit+ cells, proliferation and apoptosis in the left ventricle after myocardial infarction. Clin Transl Sci. 2009; 2: 422-30.
25. Ellison GM, Torella D, Dellegrottaglie S, et al. Endogenous cardiac stem cell activation by insulin-like growth factor-1/hepatocyte growth factor intracoronary injection fosters survival and regeneration of the infarcted pig heart. J Am Coll Cardiol. 2011; 58: 9786.
26. Wen Z, Zheng S, Zhou C, et al. Bone marrow mesenchymal stem cells for post-myocardial infarction cardiac repair: micro-RNAs as novel regulators. J Cell Mol Med. 2011; doi:10.1111/j.1582-4934.
27. Itzhaki-Alfia A, Leor J, Raanani E, et al. Patient characteristics and cell source determine the number of isolated human cardiac progenitor cells. Circulation. 2009; 120: 2559-66.
28. He JQ, Vu DM, Hunt G, et al. Human cardiac stem cells isolated from atrial appendages stably express c-kit. PLoS One. 2011; 6: e27719.
29. Fransioli J, Bailey B, Gude NA, et al. Evolution of the c-kit-positive cell response to pathological challenge in the myocardium. Stem Cells. 2008; 26: 1315-24.
30. Oh H, Bradfute SB, Gallardo TD, et al. Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc Natl Acad Sci USA. 2003; 100: 12313-8.
31. Di Nardo P, Forte G, Ahluwalia A, et al. Cardiac progenitor cells: potency and control. J Cell Physiol. 2010; 224: 590-600.
32. Wang X, Hu Q, Nakamura Y, et al. The role of the sca-1+/CD31- cardiac progenitor cell population in postinfarction left ventricular remodeling. Stem Cells. 2006; 24: 1779-88.
33. Hierlihy AM, Seale P, Lobe CG, et al. The post-natal heart contains a myocardial stem cell population. FEBS Lett. 2002; 530: 239-43.
34. Messina E, De Angelis L, Frati G, et al. Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ Res. 2004; 95: 911-21.
35. Smith RR, Barile L, Cho HC, et al. Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. Circulation. 2007; 115: 896-908.
36. Mishra R, Vijayan K, Colletti EJ, et al. Characterization and functionality of cardiac progenitor cells in congenital heart patients. Circulation. 2011; 123: 364-73.
37. Hodgkiss-Geere HM, Argyle DJ, Corcoran BM, et al. Characterisation and cardiac directed differentiation of canine adult cardiac stem cells. Vet J. 2012; 191: 176-82.
38. Andersen DC, Andersen P, Schneider M, et al. Murine "cardiospheres" are not a source of stem cells with cardiomyogenic potential. Stem Cells. 2009; 27: 1571-81.
39. Laugwitz KL, Moretti A, Lam J, et al. Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages. Nature. 2005; 433: 647-53.
40. Zhou B, Ma Q, Rajagopal S, et al. Epicardial progenitors contribute to the cardiomyocyte lineage in the developing heart. Nature. 2008; 454: 109-13.
41. Limana F, Zacheo A, Mocini D, et al. Identification of myocardial and vascular precursor cells in human and mouse epicardium. Circ Res. 2007; 101: 1255-65.
42. Castaldo C, Di Meglio F, Nurzynska D, et al. CD117-positive cells in adult human heart are localized in the subepicardium, and their activation is associated with laminin-1 and alpha6 integrin expression. Stem Cells. 2008; 26: 1723-31.
43. Leri A, Kajstura J, Anversa P. Role of cardiac stem cells in cardiac pathophysiology: a paradigm shift in human myocardial biology. Circ Res. 2011; 109: 941-61.
44. Torella D, Ellison GM, Karakikes I, et al. Resident cardiac stem cells. Cell Mol Life Sci. 2007; 64: 661-73.
45. Orlic D, Kajstura J, Chimenti S, et al. Bone marrow cells regenerate infarcted myocardium. Nature. 2001; 410: 701-5.
46. Jeong JO, Han JW, Kim JM, et al. Malignant tumor formation after transplantation of short-term cultured bone marrow mesenchymal stem cells in experimental myocardial infarction and diabetic neuropathy. Circ Res. 2011; 108: 1340-7.
47. Tokunaga M, Liu ML, Nagai T, et al. Implantation of cardiac progenitor cells using self-assembling peptide improves cardiac function after myocardial infarction. J Mol Cell Cardiol. 2010; 49: 972-83.
48. Barile L, Chimenti I, Gaetani R, et al. Cardiac stem cells: isolation, expansion and experimental use for myocardial regeneration. Nat Clin Pract Cardiovasc Med. 2007; 4: S9-14.
49. Oyama T, Nagai T, Wada H, et al. Cardiac side population cells have a potential to migrate and differentiate into cardiomyocytes in vitro and in vivo. J Cell Biol. 2007; 176: 329-41.
50. Johnston PV, Sasano T, Mills K, et al. Engraftment, differentiation, and functional benefits of autologous cardiosphere-derived cells in porcine ischemic cardiomyopathy. Circulation. 2009; 120: 1075-83, 7 p following 83.
51. Smits AM, van Laake LW, den Ouden K, et al. Human cardiomyocyte progenitor cell transplantation preserves long-term function of the infarcted mouse myocardium. Cardiovasc Res. 2009; 83: 527-35.
52. Li Z, Lee A, Huang M, et al. Imaging survival and function of transplanted cardiac resident stem cells. J Am Coll Cardiol. 2009; 53: 1229-40.
53. Rota M, Padin-Iruegas ME, Misao Y, et al. Local activation or implantation of cardiac progenitor cells rescues scarred infarcted myocardium improving cardiac function. Circ Res. 2008; 103: 107-16.
54. Chimenti I, Smith RR, Li TS, et al. Relative roles of direct regeneration versus paracrine effects of human cardiosphere-derived cells transplanted into infarcted mice. Circ Res. 2010; 106: 971-80.
55. Maxeiner H, Krehbiehl N, Muller A, et al. New insights into paracrine mechanisms of human cardiac progenitor cells. Eur J Heart Fail. 2010; 12: 730-7.
56. Huang C, Gu H, Yu Q, et al. Sca-1+ cardiac stem cells mediate acute cardioprotection via paracrine factor SDF-1 following myocardial ischemia/reperfusion. PLoS One. 2011; 6: e29246.
57. Kawaguchi N, Smith AJ, Waring CD, et al. c-kitpos GATA-4 high rat cardiac stem cells foster adult cardiomyocyte survival through IGF-1 paracrine signalling. PLoS One. 2010; 5: e14297.
58. Vrijsen KR, Sluijter JP, Schuchardt MW, et al. Cardiomyocyte progenitor cell-derived exosomes stimulate migration of endothelial cells. J Cell Mol Med. 2010; 14: 1064-70.
59. D'Amario D, Fiorini C, Campbell PM, et al. Functionally competent cardiac stem cells can be isolated from endomyocardial biopsies of patients with advanced cardiomyopathies. Circ Res. 2011; 108: 857-61.
60. Davis DR, Zhang Y, Smith RR, et al. Validation of the cardiosphere method to culture cardiac progenitor cells from myocardial tissue. PLoS One. 2009; 4: e7195.
61. Bolli R, Chugh AR, D'Amario D, et al. Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. Lancet. 2011; 378: 1847-57.
62. Makkar RR, Smith RR, Cheng K, et al. Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial. Lancet. 2012; 379: 895-904.
63. Li TS, Cheng K, Malliaras K, et al. Expansion of human cardiac stem cells in physiological oxygen improves cell production efficiency and potency for myocardial repair. Cardiovasc Res. 2011; 89: 157-65.
64. Gambini E, Pompilio G, Biondi A, et al. C-kit+ cardiac progenitors exhibit mesenchymal markers and preferential cardiovascular commitment. Cardiovasc Res. 2011; 89: 362-73.
65. Matsuura K, Nagai T, Nishigaki N, et al. Adult cardiac Sca-1-positive cells differentiate into beating cardiomyocytes. J Biol Chem. 2004; 279: 11384-91.
66. Miyamoto S, Kawaguchi N, Ellison GM, et al. Characterization of long-term cultured c-kit+ cardiac stem cells derived from adult rat hearts. Stem Cells Dev. 2010; 19: 105-16.
67. Loffredo FS, Steinhauser ML, Gannon J, et al. Bone marrow-derived cell therapy stimulates endogenous cardiomyocyte progenitors and promotes cardiac repair. Cell Stem Cell. 2011; 8: 389-98.
68. Kubo H, Jaleel N, Kumarapeli A, et al. Increased cardiac myocyte progenitors in failing human hearts. Circulation. 2008; 118: 649-57.
69. Di Meglio F, Nurzynska D, Castaldo C, et al. In vitro cultured progenitors and precursors of cardiac cell lineages from human normal and post-ischemic hearts. Eur J Histochem. 2007; 51: 275-82.
70. Urbanek K, Cesselli D, Rota M, et al. Stem cell niches in the adult mouse heart. Proc Natl Acad Sci USA. 2006; 103: 9226-31.
71. Zaruba MM, Soonpaa M, Reuter S, et al. Cardiomyogenic potential of C-kit(+)-expressing cells derived from neonatal and adult mouse hearts. Circulation. 2010; 121: 1992-2000.
72. Park JH, Lee S, Park HK, et al. The existence of cardiac myofibroblasts co-localized with cardiac stem cells in remodeled human atrial tissues of valvular heart disease with or without atrial fibrillation. J Am Coll Cardiol. 2011; 57: 122.
73. Baum J, Duffy HS. Fibroblasts and myofibroblasts: what are we talking about? J Cardiovasc Pharmacol. 2011; 57: 376-9.
74. Zhao ZQ, Puskas JD, Xu D, et al. Improvement in cardiac function with small intestine extracellular matrix is associated with recruitment of C-kit cells, myofibroblasts, and macrophages after myocardial infarction. J Am Coll Cardiol. 2010; 55: 1250-61.
75. Gherghiceanu M, Popescu LM. Cardiac telocytes - their junctions and functional implications. Cell Tissue Res. 2012; doi:10.1007/s00441-012-1333-8.
76. Gherghiceanu M, Popescu LM. Cardiomyocyte precursors and telocytes in epicardial stem cell niche: electron microscope images. J Cell Mol Med. 2010; 14: 871-7.
77. Bani D, Formigli L, Gherghiceanu M, et al. Telocytes as supporting cells for myocardial tissue organization in developing and adult heart. J Cell Mol Med. 2010; 14: 2531-8.
78. Croquelois A, Domenighetti AA, Nemir M, et al. Control of the adaptive response of the heart to stress via the Notch1 receptor pathway. J Exp Med. 2008; 205: 3173-85.
79. Boni A, Urbanek K, Nascimbene A, et al. Notch1 regulates the fate of cardiac progenitor cells. Proc Natl Acad Sci USA. 2008; 105: 15529-34.
80. Goichberg P, Bai Y, D'Amario D, et al. The ephrin A1-EphA2 system promotes cardiac stem cell migration after infarction. Circ Res. 2011; 108: 1071-83.
81. Stastna M, Chimenti I, Marban E, et al. Identification and functionality of proteomes secreted by rat cardiac stem cells and neonatal cardiomyocytes. Proteomics. 2010; 10: 245-53.
82. Li TS, Cheng K, Lee ST, et al. Cardiospheres recapitulate a niche-like microenvironment rich in stemness and cell-matrix interactions, rationalizing their enhanced functional potency for myocardial repair. Stem Cells. 2010; 28: 2088-98.
83. Zisa D, Shabbir A, Mastri M, et al. Intramuscular VEGF activates an SDF1-dependent progenitor cell cascade and an SDF1-independent muscle paracrine cascade for cardiac repair. Am J Physiol Heart Circ Physiol. 2011; 301: H2422-32.
84. Manole CG, Cismasiu V, Gherghiceanu M, et al. Experimental acute myocardial infarction: telocytes involvement in neo-angiogenesis. J Cell Mol Med. 2011; 15: 2284-96.
85. Popescu LM, Manole CG, Gherghiceanu M, et al. Telocytes in human epicardium. J Cell Mol Med. 2010; 14: 2085-93.
86. Barile L, Cerisoli F, Frati G, et al. Bone marrow-derived cells can acquire cardiac stem cells properties in damaged heart. J Cell Mol Med. 2011; 15: 63-71.
87. Wei F, Wang T, Liu J, et al. The subpopulation of mesenchymal stem cells that differentiate toward cardiomyocytes is cardiac progenitor cells. Exp Cell Res. 2011; 317: 2661-70.
88. Tang XL, Rokosh G, Sanganalmath SK, et al. Intracoronary administration of cardiac progenitor cells alleviates left ventricular dysfunction in rats with a 30-day-old infarction. Circulation. 2010; 121: 293-305.
89. Fischer KM, Din S, Gude N, et al. Cardiac progenitor cell commitment is inhibited by nuclear Akt expression. Circ Res. 2011; 108: 960-70.
90. Nakanishi C, Yamagishi M, Yamahara K, et al. Activation of cardiac progenitor cells through paracrine effects of mesenchymal stem cells. Biochem Biophys Res Commun. 2008; 374: 11-6.
91. Tang J, Wang J, Kong X, et al. Vascular endothelial growth factor promotes cardiac stem cell migration via the PI3K/Akt pathway. Exp Cell Res. 2009; 315: 3521-31.
92. Padin-Iruegas ME, Misao Y, Davis ME, et al. Cardiac progenitor cells and biotinylated insulin-like growth factor-1 nanofibers improve endogenous and exogenous myocardial regeneration after infarction. Circulation. 2009; 120: 876-87.
93. Fatma S, Selby DE, Singla RD, et al. Factors released from embryonic stem cells stimulate c-kit-FLK-1(+ve) progenitor cells and enhance neovascularization. Antioxid Redox Signal. 2010; 13: 1857-65.
94. Limana F, Bertolami C, Mangoni A, et al. Myocardial infarction induces embryonic reprogramming of epicardial c-kit(+) cells: role of the pericardial fluid. J Mol Cell Cardiol. 2010; 48: 609-18.
95. Bocchi L, Savi M, Graiani G, et al. Growth factor-induced mobilization of cardiac progenitor cells reduces the risk of arrhythmias, in a rat model of chronic myocardial infarction. PLoS One. 2011; 6: e17750.
96. Gonzalez A, Rota M, Nurzynska D, et al. Activation of cardiac progenitor cells reverses the failing heart senescent phenotype and prolongs lifespan. Circ Res. 2008; 102: 597-606.
97. Tillmanns J, Rota M, Hosoda T, et al. Formation of large coronary arteries by cardiac progenitor cells. Proc Natl Acad Sci USA. 2008; 105: 1668-73.
98. D'Amario D, Cabral-da-Silva MC, Zheng H, et al. Insulin-like growth factor-1 receptor identifies a pool of human cardiac stem cells with superior therapeutic potential for myocardial regeneration. Circ Res. 2011; 108: 1467-81.
99. Davis ME, Hsieh PC, Takahashi T, et al. Local myocardial insulin-like growth factor 1 (IGF-1) delivery with biotinylated peptide nanofibers improves cell therapy for myocardial infarction. Proc Natl Acad Sci USA. 2006; 103: 8155-60.
100. Kotlyar AA, Vered Z, Goldberg I, et al. Insulin-like growth factor I and II preserve myocardial structure in postinfarct swine. Heart. 2001; 86: 693-700.
101. Torella D, Rota M, Nurzynska D, et al. Cardiac stem cell and myocyte aging, heart failure, and insulin-like growth factor-1 overexpression. Circ Res. 2004; 94: 514-24.
102. Tateishi K, Ashihara E, Honsho S, et al. Human cardiac stem cells exhibit mesenchymal features and are maintained through Akt/GSK-3beta signaling. Biochem Biophys Res Commun. 2007; 352: 635-41.
103. Haider H, Jiang S, Idris NM, et al. IGF-1-overexpressing mesenchymal stem cells accelerate bone marrow stem cell mobilization via paracrine activation of SDF-1alpha/CXCR4 signaling to promote myocardial repair. Circ Res. 2008; 103: 1300-8.
104. Lee BC, Hsu HC, Tseng WY, et al. Cell therapy generates a favourable chemokine gradient for stem cell recruitment into the infarcted heart in rabbits. Eur J Heart Fail. 2009; 11: 238-45.
105. Li TS, Hayashi M, Ito H, et al. Regeneration of infarcted myocardium by intramyocardial implantation of ex vivo transforming growth factor-beta-preprogrammed bone marrow stem cells. Circulation. 2005; 111: 2438-45.
106. Tang YL, Zhu W, Cheng M, et al. Hypoxic preconditioning enhances the benefit of cardiac progenitor cell therapy for treatment of myocardial infarction by inducing CXCR4 expression. Circ Res. 2009; 104: 1209-16.
107. Lin HH, Chen YH, Chang PF, et al. Heme oxygenase-1 promotes neovascularization in ischemic heart by coinduction of VEGF and SDF-1. J Mol Cell Cardiol. 2008; 45: 44-55.
108. Claes F, Vandevelde W, Moons L, et al. Another angiogenesis-independent role for VEGF: SDF1-dependent cardiac repair via cardiac stem cells. Cardiovasc Res. 2011; 91: 369-70.
109. Tang JM, Wang JN, Zhang L, et al. VEGF/SDF-1 promotes cardiac stem cell mobilization and myocardial repair in the infarcted heart. Cardiovasc Res. 2011; 91: 402-11.
110. Segers VF, Tokunou T, Higgins LJ, et al. Local delivery of protease-resistant stromal cell derived factor-1 for stem cell recruitment after myocardial infarction. Circulation. 2007; 116: 1683-92.
111. Zhang G, Nakamura Y, Wang X, et al. Controlled release of stromal cell-derived factor-1 alpha in situ increases c-kit+ cell homing to the infarcted heart. Tissue Eng. 2007; 13: 2063-71.
112. Wang W, Li W, Ong LL, et al. Localized SDF-1alpha gene release mediated by collagen substrate induces CD117 stem cells homing. J Cell Mol Med. 2010; 14: 392-402.
113. Unzek S, Zhang M, Mal N, et al. SDF-1 recruits cardiac stem cell-like cells that depolarize in vivo. Cell Transplant. 2007; 16: 879-86.
114. Rodrigues CO, Shehadeh LA, Hoosien M, et al. Heterogeneity in SDF-1 expression defines the vasculogenic potential of adult cardiac progenitor cells. PLoS One. 2011; 6: e24013.
115. Zhang YH, Zhang GW, Gu TX, et al. Exogenous basic fibroblast growth factor promotes cardiac stem cell-mediated myocardial regeneration after miniswine acute myocardial infarction. Coron Artery Dis. 2011; 22: 279-85.
116. Zhang GW, Wen T, Gu TX, et al. Transmyocardial drilling revascularization combined with heparinized bFGF-incorporating stent activates resident cardiac stem cells via SDF-1/CXCR4 axis. Exp Cell Res. 2012; 318: 391-9.
117. Tateishi K, Ashihara E, Takehara N, et al. Clonally amplified cardiac stem cells are regulated by Sca-1 signaling for efficient cardiovascular regeneration. J Cell Sci. 2007; 120: 1791-800.
118. Rosenblatt-Velin N, Ogay S, Felley A, et al. Cardiac dysfunction and impaired compensatory response to pressure overload in mice deficient in stem cell antigen-1. FASEB J. 2011; 26: 229-39.
119. Takamiya M, Haider KH, Ashraf M. Identification and characterization of a novel multipotent sub-population of sca-1 cardiac progenitor cells for myocardial regeneration. PLoS One. 2011; 6: e25265.
120. Li M, Naqvi N, Yahiro E, et al. c-kit is required for cardiomyocyte terminal differentiation. Circ Res. 2008; 102: 677-85.
121. Cimini M, Fazel S, Zhuo S, et al. c-kit dysfunction impairs myocardial healing after infarction. Circulation. 2007; 116: I77-82.
122. Kuang D, Zhao X, Xiao G, et al. Stem cell factor/c-kit signaling mediated cardiac stem cell migration via activation of p38 MAPK. Basic Res Cardiol. 2008; 103: 265-73.
123. Lutz M, Rosenberg M, Kiessling F, et al. Local injection of stem cell factor (SCF) improves myocardial homing of systemically delivered c-kit + bone marrow-derived stem cells. Cardiovasc Res. 2008; 77: 143-50.
124. Kanellakis P, Slater NJ, Du XJ, et al. Granulocyte colony-stimulating factor and stem cell factor improve endogenous repair after myocardial infarction. Cardiovasc Res. 2006; 70: 117-25.
125. Guo J, Jie W, Kuang D, et al. Ischaemia/reperfusion induced cardiac stem cell homing to the injured myocardium by stimulating stem cell factor expression via NF-kappaB pathway. Int J Exp Pathol. 2009; 90: 355-64.
126. Wan J, Deng Y, Guo J, et al. Hyperhomocysteinemia inhibited cardiac stem cell homing into the peri-infarcted area post myocardial infarction in rats. Exp Mol Pathol. 2011; 91: 411-8.
127. Matsuura K, Honda A, Nagai T, et al. Transplantation of cardiac progenitor cells ameliorates cardiac dysfunction after myocardial infarction in mice. J Clin Invest. 2009; 119: 2204-17.
128. Mohri T, Fujio Y, Maeda M, et al. Leukemia inhibitory factor induces endothelial differentiation in cardiac stem cells. J Biol Chem. 2006; 281: 6442-7.
129. Iwakura T, Mohri T, Hamatani T, et al. STAT3/Pim-1 signaling pathway plays a crucial role in endothelial differentiation of cardiac resident Sca-1+ cells both in vitro and in vivo. J Mol Cell Cardiol. 2011; 51: 207-14.
130. Mohri T, Fujio Y, Obana M, et al. Signals through glycoprotein 130 regulate the endothelial differentiation of cardiac stem cells. Arterioscler Thromb Vasc Biol. 2009; 29: 754-60.
131. Goumans MJ, de Boer TP, Smits AM, et al. TGF-beta1 induces efficient differentiation of human cardiomyocyte progenitor cells into functional cardiomyocytes in vitro. Stem Cell Res. 2007; 1: 138-49.
132. Rosenblatt-Velin N, Lepore MG, Cartoni C, et al. FGF-2 controls the differentiation of resident cardiac precursors into functional cardiomyocytes. J Clin Invest. 2005; 115: 1724-33.
133. Aghila Rani KG, Kartha CC. Effects of epidermal growth factor on proliferation and migration of cardiosphere-derived cells expanded from adult human heart. Growth Factors. 2010; 28: 157-65.
134. Brunner S, Huber BC, Fischer R, et al. G-CSF treatment after myocardial infarction: impact on bone marrow-derived vs cardiac progenitor cells. Exp Hematol. 2008; 36: 695-702.
135. Scobioala S, Klocke R, Kuhlmann M, et al. Up-regulation of nestin in the infarcted myocardium potentially indicates differentiation of resident cardiac stem cells into various lineages including cardiomyocytes. FASEB J. 2008; 22: 1021-31.
136. Zelarayan LC, Noack C, Sekkali B, et al. Beta-catenin downregulation attenuates ischemic cardiac remodeling through enhanced resident precursor cell differentiation. Proc Natl Acad Sci USA. 2008; 105: 19762-7.
137. Forte G, Carotenuto F, Pagliari F, et al. Criticality of the biological and physical stimuli array inducing resident cardiac stem cell determination. Stem Cells. 2008; 26: 2093-103.
138. Bonauer A, Carmona G, Iwasaki M, et al. MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science. 2009; 324: 1710-3.
139. Limana F, Germani A, Zacheo A, et al. Exogenous high-mobility group box 1 protein induces myocardial regeneration after infarction via enhanced cardiac C-kit+ cell proliferation and differentiation. Circ Res. 2005; 97: e73-83.
140. Rossini A, Zacheo A, Mocini D, et al. HMGB1-stimulated human primary cardiac fibroblasts exert a paracrine action on human and murine cardiac stem cells. J Mol Cell Cardiol. 2008; 44: 683-93.
141. Limana F, Esposito G, D'Arcangelo D, et al. HMGB1 attenuates cardiac remodelling in the failing heart via enhanced cardiac regeneration and miR-206-mediated inhibition of TIMP-3. PLoS One. 2011; 6: e19845.
142. Sluijter JP, van Mil A, van Vliet P, et al. MicroRNA-1 and -499 regulate differentiation and proliferation in human-derived cardiomyocyte progenitor cells. Arterioscler Thromb Vasc Biol. 2010; 30: 859-68.
143. Wilson KD, Hu S, Venkatasubrahmanyam S, et al. Dynamic microRNA expression programs during cardiac differentiation of human embryonic stem cells: role for miR-499. Circ Cardiovasc Genet. 2010; 3: 426-35.
144. Ivey KN, Srivastava D. MicroRNAs as regulators of differentiation and cell fate decisions. Cell Stem Cell. 2010; 7: 36-41.
145. Zhao Y, Samal E, Srivastava D. Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature. 2005; 436: 214-20.
146. Wang J, Greene SB, Bonilla-Claudio M, et al. Bmp signaling regulates myocardial differentiation from cardiac progenitors through a microRNA-mediated mechanism. Dev Cell. 2010; 19: 903-12.
147. Sirish P, Lopez JE, Li N, et al. MicroRNA profiling predicts a variance in the proliferative potential of cardiac progenitor cells derived from neonatal and adult murine hearts. J Mol Cell Cardiol. 2011; 52: 264-72.
148. Kapinas K, Kessler C, Ricks T, et al. miR-29 modulates Wnt signaling in human osteoblasts through a positive feedback loop. J Biol Chem. 2010; 285: 25221-31.
149. Deb A, Davis BH, Guo J, et al. SFRP2 regulates cardiomyogenic differentiation by inhibiting a positive transcriptional autofeedback loop of Wnt3a. Stem Cells. 2008; 26: 35-44.
150. Oikonomopoulos A, Sereti KI, Conyers F, et al. Wnt signaling exerts an antiproliferative effect on adult cardiac progenitor cells through IGFBP3. Circ Res. 2011; 109: 1363-74.
151. Hu S, Huang M, Nguyen PK, et al. Novel microRNA prosurvival cocktail for improving engraftment and function of cardiac progenitor cell transplantation. Circulation. 2011; 124: S27-34.
152. Liu J, van Mil A, Vrijsen K, et al. MicroRNA-155 prevents necrotic cell death in human cardiomyocyte progenitor cells via targeting RIP1. J Cell Mol Med. 2011; 15: 1474-82.
153. Crippa S, Cassano M, Messina G, et al. miR669a and miR669q prevent skeletal muscle differentiation in postnatal cardiac progenitors. J Cell Biol. 2011; 193: 1197-212.
154. Bailey B, Izarra A, Alvarez R, et al. Cardiac stem cell genetic engineering using the alphaMHC promoter. Regen Med. 2009; 4: 823-33.
155. Suzuki G, Iyer V, Cimato T, et al. Pravastatin improves function in hibernating myocardium by mobilizing CD133+ and cKit+ bone marrow progenitor cells and promoting myocytes to reenter the growth phase of the cardiac cell cycle. Circ Res. 2009; 104: 255-64, 10p following 64.
156. Kanashiro-Takeuchi RM, Takeuchi LM, Rick FG, et al. Activation of growth hormone releasing hormone (GHRH) receptor stimulates cardiac reverse remodeling after myocardial infarction (MI). Proc Natl Acad Sci USA. 2011; 109: 559-63.
157. Li YM, Guo YP, Liu Y. Cancer chemotherapy induces cardiotoxicity by targeting cardiac stem cells. J Cell Mol Med. 2010; 14: 2630-2.
158. Altarche-Xifro W, Curato C, Kaschina E, et al. Cardiac c-kit+AT2+ cell population is increased in response to ischemic injury and supports cardiomyocyte performance. Stem Cells. 2009; 27: 2488-97.
159. Qi Y, Li H, Shenoy V, et al. Moderate cardiac-selective overexpression of angiotensin type 2 receptor protects cardiac functions from ischemic injury. Exp Physiol. 2012; 97: 89-101.
160. Ellison GM, Torella D, Karakikes I, et al. Acute beta-adrenergic overload produces myocyte damage through calcium leakage from the ryanodine receptor 2 but spares cardiac stem cells. J Biol Chem. 2007; 282: 11397-409.
161. Angert D, Berretta RM, Kubo H, et al. Repair of the injured adult heart involves new myocytes potentially derived from resident cardiac stem cells. Circ Res. 2011; 108: 1266-73.
162. Brinckmann M, Kaschina E, Altarche-Xifro W, et al. Estrogen receptor alpha supports cardiomyocytes indirectly through post-infarct cardiac c-kit+ cells. J Mol Cell Cardiol. 2009; 47: 66-75.
163. Craig EA, Parker P, Austin AF, et al. Involvement of the MEKK1 signaling pathway in the regulation of epicardial cell behavior by hyaluronan. Cell Signal. 2010; 22: 968-76.
164. Lionetti V, Cantoni S, Cavallini C, et al. Hyaluronan mixed esters of butyric and retinoic acid affording myocardial survival and repair without stem cell transplantation. J Biol Chem. 2010; 285: 9949-61.
165. Maioli M, Santaniello S, Montella A, et al. Hyaluronan esters drive Smad gene expression and signaling enhancing cardiogenesis in mouse embryonic and human mesenchymal stem cells. PLoS One. 2010; 5: e15151.
166. Hoch M, Fischer P, Stapel B, et al. Erythropoietin preserves the endothelial differentiation capacity of cardiac progenitor cells and reduces heart failure during anticancer therapies. Cell Stem Cell. 2011; 9: 131-43.
167. Gaetani R, Ledda M, Barile L, et al. Differentiation of human adult cardiac stem cells exposed to extremely low-frequency electromagnetic fields. Cardiovasc Res. 2009; 82: 411-20.
168. Ferreira-Martins J, Rondon-Clavo C, Tugal D, et al. Spontaneous calcium oscillations regulate human cardiac progenitor cell growth. Circ Res. 2009; 105: 764-74.
169. Ellison GM, Galuppo V, Vicinanza C, et al. Cardiac stem and progenitor cell identification: different markers for the same cell? Front Biosci (Schol Ed). 2010; 2: 641-52.
170. Lyngbaek S, Schneider M, Hansen JL, et al. Cardiac regeneration by resident stem and progenitor cells in the adult heart. Basic Res Cardiol. 2007; 102: 101-14.
171. Leri A. Human cardiac stem cells: the hear of a truth. Circulation. 2009; 120: 2515-8.